Literature DB >> 646215

Problems in diagnosis and therapy of Mycobacterium fortuitum infections.

J R Dalovisio, G A Pankey.   

Abstract

Mycobacterium fortuitum was isolated 11 times from 8 patients during a 6-year period. Six of the isolates were from sputum; one was from aspiration of a lymph node, and 4 were from wound cultures. The isolation from sputum was believed not to be associated with pulmonary infection in all 6 instances. The difficulty in diagnosis and therapy of infections with Mycobacterium fortuitum is illustrated by these cases and by others from the literature. Amikacin and doxycycline may offer some therapeutic benefit for patients with Mycobacterium fortuitum infections.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646215     DOI: 10.1164/arrd.1978.117.4.625

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Fatal infection with Mycobacterium fortuitum associated with oesophageal achalasia.

Authors:  G Varghese; R Shepherd; P Watt; J H Bruce
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

2.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.

Authors:  J M Swenson; C Thornsberry; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

4.  Mycobacterial infection following blepharoplasty.

Authors:  R Kevitch; B Guyuron
Journal:  Aesthetic Plast Surg       Date:  1991       Impact factor: 2.326

5.  Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  C W Choi; D R Cha; Y J Kwon; W Y Cho; H J Pyo; H K Kim
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.